Coverart for item
The Resource Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary, Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies, (electronic resource)

Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary, Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies, (electronic resource)

Label
Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary
Title
Envisioning a transformed clinical trials enterprise in the United States
Title remainder
establishing an agenda for 2020 : workshop summary
Statement of responsibility
Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Contributor
Subject
Genre
Language
eng
Summary
"There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop"--Publisher's description
Cataloging source
IDEBK
Illustrations
  • illustrations
  • charts
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Weisfeld, Neil E
  • English, Rebecca A
  • Claiborne, Anne B
  • Institute of Medicine (U.S.)
http://library.link/vocab/subjectName
  • Clinical trials
  • Clinical trials
  • Clinical trials
  • Drug development
  • Drugs
  • Pharmaceutical industry
  • Business and medicine
  • Clinical Trials as Topic
  • Drug Design
  • Drug Industry
  • Drug Industry
  • Randomized Controlled Trials as Topic
  • United States
  • United States
Label
Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary, Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies, (electronic resource)
Instantiates
Publication
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Introduction -- Integrating community practice and clinical trials -- Improving public participation in clinical trials -- Creating a new business model for clinical trials -- Building an infrastructure to support clinical trials -- Suggesting an agenda for transforming elements of the clinical trials enterprise -- Discussion paper: the clinical trials enterprise in the united states: a call for disruptive innovation -- Discussion paper: developing a robust clinical trials workforce -- Discussion paper: transforming the economics of clinical trials -- Discussion paper: developing a clinical trials infrastructure -- Discussion paper: Canadian strategy on patient-oriented research -- Discussion paper: health research as a public good -- Discussion paper: novel ways to get good trial data: the UK experience -- IOM staff paper: context and glossary of select terms associated with the clinical trials enterprise
Control code
813396119
Extent
1 online resource (xvi, 232 pages)
Form of item
online
Isbn
9786613948823
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations (some color).
Specific material designation
remote
System control number
(OCoLC)813396119
Label
Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary, Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies, (electronic resource)
Publication
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Introduction -- Integrating community practice and clinical trials -- Improving public participation in clinical trials -- Creating a new business model for clinical trials -- Building an infrastructure to support clinical trials -- Suggesting an agenda for transforming elements of the clinical trials enterprise -- Discussion paper: the clinical trials enterprise in the united states: a call for disruptive innovation -- Discussion paper: developing a robust clinical trials workforce -- Discussion paper: transforming the economics of clinical trials -- Discussion paper: developing a clinical trials infrastructure -- Discussion paper: Canadian strategy on patient-oriented research -- Discussion paper: health research as a public good -- Discussion paper: novel ways to get good trial data: the UK experience -- IOM staff paper: context and glossary of select terms associated with the clinical trials enterprise
Control code
813396119
Extent
1 online resource (xvi, 232 pages)
Form of item
online
Isbn
9786613948823
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
illustrations (some color).
Specific material designation
remote
System control number
(OCoLC)813396119

Library Locations

  • Ellis LibraryBorrow it
    1020 Lowry Street, Columbia, MO, 65201, US
    38.944491 -92.326012
  • Engineering Library & Technology CommonsBorrow it
    W2001 Lafferre Hall, Columbia, MO, 65211, US
    38.946102 -92.330125
  • Fisher Delta Research CenterBorrow it
    2-64 Agricultural Bldg, Columbia, MO, 65201, US
    38.958397 -92.303491
  • Geological Sciences LibraryBorrow it
    201 Geological Sciences, Columbia, MO, 65211, US
    38.947375 -92.329062
  • J. Otto Lottes Health Sciences LibraryBorrow it
    1 Hospital Dr, Columbia, MO, 65201, US
    38.939544 -92.328377
  • Journalism LibraryBorrow it
    102 Reynolds Jrnlism Institute, Columbia, MO, 65211, US
    38.947290 -92.328025
  • Mathematical Sciences LibraryBorrow it
    104 Ellis Library, Columbia, MO, 65201, US
    38.944377 -92.326537
  • University ArchivesBorrow it
    Columbia, MO, 65201, US
  • University Archives McAlester AnnexBorrow it
    703 Lewis Hall, Columbia, MO, 65211, US
    38.934630 -92.342290
  • University of Missouri Libraries DepositoryBorrow it
    2908 Lemone Blvd, Columbia, MO, 65211, US
    38.919360 -92.291620
  • Zalk Veterinary Medical LibraryBorrow it
    Veterinary Medicine West, Columbia, MO, 65211, US
    38.941099 -92.317911
Processing Feedback ...